A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Biotechnology is the exploitation of biological processes for the development of technologies and products for a specific use. GlobalData’s Strategic Intelligence report on biotech details how recent ...

The company’s cross-disciplinary team lead by a Triple-Dr, Berenika Maciejewicz, applies bioengineering and AI towards human lifespan and healthspan extension.

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

Venture capitalists point to a surge in M&A and a glint of revival in the IPO arena as signs of better days ahead.

The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.

Loopworm owns and operates its primary production facility in Bangalore, with a current capacity of 6,000 tons annually.